Trial Profile

Immunological Non-inferiority Between Two Process-manufactured Influenza Vaccines in Adults Aged 18 to 60 Years

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza A virus vaccine-H1N1 (Primary)
Indications Influenza A virus H1N1 subtype
Focus Pharmacodynamics; Registrational
Sponsors GlaxoSmithKline; GlaxoSmithKline Biologicals; GSK

Most Recent Events

21 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
18 Nov 2010 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
03 Nov 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com